Maryland awarded more than $520,000 for multi-cancer early detection screening using 20/20 BioLabs’ OneTest blood-based assay, funding testing for over 1,400 firefighters. The program expands the number of funded assays by 225% versus 2025 and is expected to run in April or May, generating real-world evidence intended to support future FDA and CMS engagements for reimbursement of OneTest for Cancer.